CN102552536B - 杞茯组合物及制备方法 - Google Patents
杞茯组合物及制备方法 Download PDFInfo
- Publication number
- CN102552536B CN102552536B CN201010616733.XA CN201010616733A CN102552536B CN 102552536 B CN102552536 B CN 102552536B CN 201010616733 A CN201010616733 A CN 201010616733A CN 102552536 B CN102552536 B CN 102552536B
- Authority
- CN
- China
- Prior art keywords
- medlar
- tuckahoe
- poria
- extract powder
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 240000002624 Mespilus germanica Species 0.000 title abstract 10
- 235000017784 Mespilus germanica Nutrition 0.000 title abstract 10
- 235000000560 Mimusops elengi Nutrition 0.000 title abstract 10
- 235000007837 Vangueria infausta Nutrition 0.000 title abstract 10
- 244000248825 Peltandra virginica Species 0.000 title abstract 9
- 235000001188 Peltandra virginica Nutrition 0.000 title abstract 9
- 235000008599 Poria cocos Nutrition 0.000 title abstract 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 59
- 239000000284 extract Substances 0.000 claims abstract description 50
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 48
- 239000000843 powder Substances 0.000 claims abstract description 38
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims abstract description 22
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960003987 melatonin Drugs 0.000 claims abstract description 22
- 108010011485 Aspartame Proteins 0.000 claims abstract description 16
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 16
- 229960003438 aspartame Drugs 0.000 claims abstract description 16
- 235000010357 aspartame Nutrition 0.000 claims abstract description 16
- 239000000605 aspartame Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002775 capsule Substances 0.000 claims abstract description 10
- 229960004106 citric acid Drugs 0.000 claims abstract description 9
- 235000013305 food Nutrition 0.000 claims abstract description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 36
- 239000003480 eluent Substances 0.000 claims description 21
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 21
- 238000001291 vacuum drying Methods 0.000 claims description 21
- 239000011347 resin Substances 0.000 claims description 18
- 229920005989 resin Polymers 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 244000241838 Lycium barbarum Species 0.000 claims description 14
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 14
- 235000015468 Lycium chinense Nutrition 0.000 claims description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 230000000274 adsorptive effect Effects 0.000 claims description 11
- 238000013019 agitation Methods 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 2
- 206010008570 Chloasma Diseases 0.000 abstract description 34
- 208000003351 Melanosis Diseases 0.000 abstract description 34
- 230000000694 effects Effects 0.000 abstract description 19
- 239000008187 granular material Substances 0.000 abstract description 16
- 208000019116 sleep disease Diseases 0.000 abstract description 8
- 208000020685 sleep-wake disease Diseases 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 7
- 239000007864 aqueous solution Substances 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 32
- 230000006870 function Effects 0.000 description 14
- 239000008280 blood Substances 0.000 description 13
- 230000008859 change Effects 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 230000007958 sleep Effects 0.000 description 11
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 10
- 206010022437 insomnia Diseases 0.000 description 10
- 239000008107 starch Substances 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- -1 between 20-60 order Substances 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 241000532370 Atla Species 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 235000007466 Corylus avellana Nutrition 0.000 description 2
- 240000003211 Corylus maxima Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000874 microwave-assisted extraction Methods 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- 238000002562 urinalysis Methods 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 244000241796 Christia obcordata Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000019872 Drug Eruptions Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- DIWRORZWFLOCLC-UHFFFAOYSA-N Lorazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 入组数 | 脱落数 | 显效数 | 有效数 | 总有效率% |
对照组 | 50例 | 1例 | 8 | 26 | 69.4 |
受试组1 | 50例 | 0例 | 10 | 28 | 76 |
受试组2 | 50例 | 1 | 8 | 27 | 71.4 |
组别 | 入组数 | 脱落数 | 一个月 | 两个月 | 复发率% |
对照组 | 34 | 0例 | 12 | 17 | 85.2 |
受试组1 | 38 | 0例 | 3 | 8 | 28.9 |
受试组2 | 35 | 0例 | 4 | 7 | 31.4 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010616733.XA CN102552536B (zh) | 2010-12-30 | 2010-12-30 | 杞茯组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010616733.XA CN102552536B (zh) | 2010-12-30 | 2010-12-30 | 杞茯组合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552536A CN102552536A (zh) | 2012-07-11 |
CN102552536B true CN102552536B (zh) | 2014-05-14 |
Family
ID=46399991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010616733.XA Expired - Fee Related CN102552536B (zh) | 2010-12-30 | 2010-12-30 | 杞茯组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552536B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102989195A (zh) * | 2012-11-03 | 2013-03-27 | 绵阳市华神空气动力技术应用厂 | 天然产物中有效成分的提取干燥方法及装置 |
CN107320455A (zh) * | 2017-08-10 | 2017-11-07 | 吉林省中亿医药包装有限公司 | 一种桦树茸滴丸及制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101559171A (zh) * | 2009-06-01 | 2009-10-21 | 孙志华 | 一种用于祛斑的中药 |
-
2010
- 2010-12-30 CN CN201010616733.XA patent/CN102552536B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101559171A (zh) * | 2009-06-01 | 2009-10-21 | 孙志华 | 一种用于祛斑的中药 |
Non-Patent Citations (8)
Title |
---|
天狮宣教部.天狮系列产品写真(八)天狮益康胶囊.《中国保健营养》.2001,(第12期),第53页"天狮梦珍冲剂"项下. |
天狮宣教部.天狮系列产品写真(八)天狮益康胶囊.《中国保健营养》.2001,(第12期),第53页"天狮梦珍冲剂"项下. * |
微波提取山楂中总黄酮的正交实验研究;郭锦棠等;《中国药学杂志》;20050131;第40卷(第2期);第113页2.2,2.4项下,表1 * |
微波法与传统工艺提取枸杞多糖的比较研究;陈金娥等;《中成药》;20080430;第28卷(第4期);第574页左栏"1.3.1 微波提取"项下,第575页右栏第1-3行 * |
微波法提取茯苓多糖的工艺研究;杜玲玲等;《中国药业》;20090131;第18卷(第1期);第38页右栏第1-2行 * |
杜玲玲等.微波法提取茯苓多糖的工艺研究.《中国药业》.2009,第18卷(第1期),第38页右栏第1-2行. |
郭锦棠等.微波提取山楂中总黄酮的正交实验研究.《中国药学杂志》.2005,第40卷(第2期),第113页2.2,2.4项下,表1. |
陈金娥等.微波法与传统工艺提取枸杞多糖的比较研究.《中成药》.2008,第28卷(第4期),第574页左栏"1.3.1 微波提取"项下,第575页右栏第1-3行. |
Also Published As
Publication number | Publication date |
---|---|
CN102552536A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103784933B (zh) | 复发性口腔溃疡散 | |
CN103355655A (zh) | 一种具有改善营养性贫血功能的组合物及其制备方法 | |
CN103446525A (zh) | 治疗皮肤病的中药组合物及其制备方法和应用 | |
CN105879004A (zh) | 一种具有美容功能的组合物及其制备方法与应用 | |
CN102552536B (zh) | 杞茯组合物及制备方法 | |
CN113209166A (zh) | 一种含烟酰胺单核苷酸的抗衰老中药组合物及其制备方法 | |
CN105999113B (zh) | 一种治疗顽固性失眠的中药组合物及其制备方法 | |
CN102266484B (zh) | 一种防治心脑血管疾病的葛根酒及制备方法和应用 | |
CN104225295B (zh) | 用于改善睡眠的组合物及其制备方法和应用 | |
CN103341074A (zh) | 抑眩宁颗粒在制备治疗失眠药物中的应用 | |
CN104000181A (zh) | 一种用于缓解体力疲劳的组合物及其制备方法 | |
CN109529010A (zh) | 一种治疗变应性鼻炎的中药组合物及其应用 | |
AU2010358534A1 (en) | Anti-fatigue composition of plant material and preparation method, use and products thereof | |
CN109010514A (zh) | 抗高原反应的组合物、保健品及制备方法 | |
CN112869160B (zh) | 一种含叶酸的祛斑组合物及其制备方法 | |
CN101804123A (zh) | 一种具有抗疲劳功效的植物原料组合物、其制备方法、用途及其产品 | |
CN100500174C (zh) | 一种用于降血糖的药物组合物及其制备方法和用途 | |
TWI721367B (zh) | 調節內分泌、提高免疫力、延緩衰老以及預防或治療便秘的組合物、其應用及其製備方法 | |
CN104069171B (zh) | 一种抗抑郁的药物组合物及其制备方法和用途 | |
CN105833055A (zh) | 一种治疗“三高”的中药组合物、其制备方法和应用 | |
CN105616561A (zh) | 一种治疗卵巢早衰的药物组合物 | |
CN104510972A (zh) | 一种治疗哮喘的中药组合物及其制备方法 | |
CN112316051A (zh) | 养血化痰中药组合物及其中药制剂、制备方法和应用 | |
CN110664922A (zh) | 一种具有祛黄褐斑功能的组合物及其制备方法和应用 | |
CN110250514A (zh) | 祛黄褐斑的保健食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT CO., LTD. TIENS GROUP CO., LTD. Effective date: 20140922 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140922 Address after: 301700, No. 18, Xinyuan Road, Wuqing Development Zone, Tianjin Patentee after: TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT Co.,Ltd. Address before: 301700, No. 18, Xinyuan Road, Wuqing Development Zone, Tianjin Patentee before: TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT Co.,Ltd. Patentee before: TIANJIN TIANSHI LIFE-RESOURCES Co.,Ltd. Patentee before: TIENS GROUP Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140514 |
|
CF01 | Termination of patent right due to non-payment of annual fee |